Germany sticks to recommendation on vaccine switch after first Astra dose
BERLIN (Reuters) - Germany's vaccine commission stuck to its recommendation on Thursday that people aged under 60 who have received one shot of AstraZeneca's COVID-19 vaccine should receive an mRNA vaccine as their second dose.
The commission, known as STIKO, said the second dose should be administered twelve weeks after the AstraZeneca shot.
Two mRNA vaccines, one from Pfizer/BioNTech and one from Moderna, are currently approved for use in Germany.
(Reporting by Caroline Copley, editing by Thomas Escritt)
© Copyright Reuters Ltd. All rights reserved. The information contained in this news report may not be published, broadcast or otherwise distributed without the prior written authority of Reuters Ltd.